S&P Biotech SPDR (XBI)
$112.89
0.42 (0.37%)
XBI Stock Quote Delayed 30 Minutes
Previous Close
$112.89
Market Cap
6.10B
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
5.05M
Day's Range
111.95 - 114.28
52-Week Range
62.94 - 115.77
Dividend & Yield
0.23 (0.20%)
XBI Stock Predictions, Articles, and S&P Biotech SPDR News
First-Mover Advantage Will Benefit Amarin Stock More Than You Think
There’s no reason Amarin stock won’t become a big success with Vascepa, especially with access to millions of patients.
4 Top Stock Trades for Friday: MU, Biotech, Bitcoin
Bitcoin, Biotech, Micron and Starbucks were our top stock trades to watch. Here's how the charts are setting up going into Friday.
Hexo Stock Is Down — But Not Out
HEXO stock is down 50% since the end of April. But inside this support zone, the bulls can mount a 20% rally if headlines cooperate.
7 Biotech ETFs That Should Remain Healthy
The healthcare sector has been the worst performing on the S&P 500 in 2019, but these biotech ETFs are still worth a look.
Nasdaq Today: iQiyi Surges on Award; Intel, Cisco Struggle
Memory stocks like Micron and semiconductor stocks like AMD were on the move in the Nasdaq today. Intel and Cisco weren't so lucky though.
IBB is up Over 5%, But the Market May Retest its Lows
This morning I am recommending a bearish trade on the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).
Biotech ETFs Are the Best Way to Play the Recovering Sector
The biotech sector peaked in 2015. While it bounced back from lows, biotech ETFs give investors exposure to the sector as it recovers.
Best ETFs for 2018: The SPDR S&P Biotech ETF (XBI) Will Continue to Rock
XBI can profit from full drug pipelines, an improving regulatory climate, high short interest and strengthening technicals.
Bet on Biogen Inc for Easy Profits Into the New Year
Biotech stocks are scary when they are falling. Sell downside risk into BIIB stock support with confidence for a chance at free profits.
